Mariner
ATOS icon

Mariner’s Atossa Therapeutics ATOS Stock Holding History

Mariner’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-674
Closed -$6.8K – 3486
2025
Q1 		$6.8K Buy
+674
New +$8.18K ﹤0.01% 3420
2024
Q3 		– Sell
-7,061
Closed -$126K – 3291
2024
Q2 		$126K Hold
7,061
– – ﹤0.01% 2907
2024
Q1 		$191K Hold
7,061
– – ﹤0.01% 2789
2023
Q4 		$93.2K Hold
7,061
– – ﹤0.01% 2863
2023
Q3 		$78K Buy
7,061
+67
+1% +$972 ﹤0.01% 2715
2023
Q2 		$132K Hold
6,994
– – ﹤0.01% 2577
2023
Q1 		$76K Buy
6,994
+3
+0% +$33 ﹤0.01% 2617
2022
Q4 		$55K Hold
6,991
– – ﹤0.01% 2602
2022
Q3 		$87K Buy
+6,991
New +$102K ﹤0.01% 2230
2021
Q4 		– Sell
-7,724
Closed -$378K – 1154
2021
Q3 		$378K Buy
7,724
+67
+0.9% +$3.9K ﹤0.01% 898
2021
Q2 		$726K Buy
+7,657
New +$405K ﹤0.01% 732

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return